The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Thursday, November 08, 2018
Mundipharma announced the European Decentralised Procedure (DCP) license variation application for flutiform has closed with a positive opinion.
read more
Tuesday, November 06, 2018
Janssen Pharmaceuticals has initiated a voluntary recall of one lot of ORTHO-NOVUM 1/35 Tablets and two lots of ORTHO-NOVUM 7/7/7 Tablets to the ...
read more
Monday, November 05, 2018
AcelRx Pharmaceuticals announced the approval of Dsuvia by the FDA.
read more
Monday, November 05, 2018
FDA is alerting patients that the labels attached to some EpiPen and EpiPen auto-injectors may block access to the auto-injector and prevent the ...
read more
Friday, November 02, 2018
Aquestive announced the FDA approved Sympazan oral film for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome in patients 2...
read more
Thursday, November 01, 2018
Heron announced the submission of its NDA to the FDA for HTX-011.
read more
Thursday, October 25, 2018
Impax announced the company is extending the expiration dates for certain lots of its epinephrine injection, USP auto-injector, 0.15 mg and 0.3 mg, ...
read more
Biohaven announced that the first participant was dosed with BHV-3500, a third generation calcitonin gene-related peptide (CGRP) receptor antagonist.
read more
Tuesday, October 16, 2018
Cannabics announced the results of its pilot study to test the efficacy of Cannabics capsules for the treatment of cancer anorexia-cachexia syndrome (...
read more
AcelRx announced the Anesthetic and Analgesic Drug Products Advisory Committee of the FDA voted in favor of recommending the approval of Dsuvia for ...
read more
Monday, September 24, 2018
Boston Scientific announced the FDA has approved its PMA application to market the Eluvia Drug-Eluting Vascular Stent System, specifically developed ...
read more
Thursday, September 13, 2018
Regeneron announced the FDA has accepted for review the sBLA of Eylea Injection for the treatment of diabetic retinopathy, the leading cause of vision...
read more
Wednesday, September 12, 2018
Biohaven has submitted an IND application to the FDA to evaluate the safety and tolerability of BHV-3500, the first small molecule CGRP receptor ...
read more
Monday, September 10, 2018
The FDA approved Cassipa sublingual film for the maintenance treatment of opioid dependence.
read more
Thursday, September 06, 2018
Neumentum announced it completed dosing the first cohort of patients in its phase I study of NTM-001 (pre-mixed bag ketorolac for continuous infusion)...
read more